KATAMARYN Trademark

Trademark Overview

On Wednesday, October 4, 2023, a trademark application was filed for KATAMARYN with the United States Patent and Trademark Office. The USPTO has given the KATAMARYN trademark a serial number of 98209131. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, May 24, 2024. This trademark is owned by Boston Pharmaceuticals, Inc.. The KATAMARYN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals, diseases, and clinical trials; providing medical and scientific research information
katamaryn

General Information

Serial Number98209131
Word MarkKATAMARYN
Filing DateWednesday, October 4, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, May 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals, diseases, and clinical trials; providing medical and scientific research information

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 13, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoston Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, May 23, 2024ASSIGNED TO EXAMINER
Friday, May 24, 2024SUSPENSION LETTER WRITTEN
Friday, May 24, 2024LETTER OF SUSPENSION E-MAILED
Friday, May 24, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, October 7, 2023NEW APPLICATION ENTERED
Friday, October 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

katamaryn medical research scientific providing information trials clinical pharmaceuticals diseases field